EB-5 Investment Live Webinar: November 26th @ 4PM EST - Register Now!
OUR APPROACH AS EARLY-STAGE INVESTORS is to take the lessons we have learned from our past successes and failures and apply them to help management teams proactively navigate the challenges in building companies.
LCP Ventures focuses its resources on Seed, Early-Stage and Series A companies with the belief in investing alongside strategic co-investors and established venture capital firms in the United States and abroad.
We are sector agnostic as we look for innovative ideas with outstanding management teams in sectors with exceptional growth potential.
We invest in businesses that can establish formidable barriers to entry through strong IP, and that have an identifiable exit strategy.
Established for the Division of Pediatric Cardiology at Columbia University Medical Center (CUMC), the Babies Heart Fund (BHF) was founded in 1986 by Robert Roskind, Chairman & Founder of The LCP Group, L.P., along with other parents whose children had a need for advancements in congenital heart disease (CHD). Mr. Roskind served as the original Chairman of the Fund for 14 years at which time his son, Scott Roskind, took over as Co-Chairman with John Minio. Today, the board has 24 members, two co-chairs, and six vice chairs. BHF events include a major gala event with world-renowned celebrities, sold-out golf outings, art auctions, and young professional events.
Initially, BHF paid for training interns and fellows. Today, the Babies Heart Fund is devoted to supporting vital research initiatives to help save and improve the lives of babies and adolescents with congenital heart disease. All donations made to the Babies Heart Fund are used toward funding the innovative research conducted by CUMC physicians and surgeons to benefit pediatric cardiology and cardiac surgery patients globally, and to support transitional care programs for young adults who require special cardiac expertise.
– Scott Roskind, Managing Partner
CUMC is one of the largest pediatric cardiology and cardiovascular surgery centers in the United States. It performed the first pediatric heart transplant in the U.S. on a four-year-old child in 1984. CUMC is consistently ranked among the “Best Hospitals for Pediatric Cardiology & Heart Surgery” by U.S. News & World Report. With a growing number of international referrals, it is also becoming a top destination for the world’s most
complex pediatric cardiac cases. Currently, CUMC performs more than 700 CHD surgeries per year with overall survival rates above 98%. And, the Pediatric Cardiology department handles approximately 44,000 outpatient visits annually.
LCP continues to support the Babies Heart Fund and has funded two chairs. The first in honor of Dr. James R. Malm, chief of cardiothoracic surgery, who transformed the program of both adult and pediatric cardiac surgery, and the second in honor of renowned pediatric cardiologist Dr. Welton M. Gersony. The gifts were used to fund two pediatric cardiology professorships at the College of Physicians & Surgeons.
As Executive Vice President of Ventures for The LCP Group, L.P. (LCP), Justin is responsible for sourcing and managing early-stage investment opportunities.
Prior to joining LCP, Justin was the CEO of Bayside Corporation, a publicly traded crypto-asset and blockchain infrastructure company with locations throughout the United States. Prior to Bayside, he was a portfolio manager at RiverPark Funds, a private investment management firm founded by former Baron Fund executives, where he created and managed a low-beta hedged equity mutual fund. Prior to this, Justin was a managing partner at Wavecrest Asset Management and was focused on liquid and risk-managed derivatives-based solutions for institutional and individual investors.
Previously, Justin spent more than a decade in leadership roles at Morgan Stanley, UBS Wealth
Management, Merrill Lynch in structured investment sales, private wealth advisement, capital markets sales, and equity trading.
Justin holds a B.A. in International Relations from Lehigh University where he was a Martindale Scholar.
Inception Year: 2024
Platform: Equity (or Debt)
Status: Active
Investment Description: Here is the description of this investment, etc.
Press Release: LINK HERE
Project Location
Key Attributes
